Cancer incidence in adolescents and young adults in the United States, 1992–1997

Wu, Xiao‐Cheng; Chen, Vivien W.; Steele, Brooke; Roffers, Steven D.; Klotz, Judith B.; Correa, Catherine N.; Carozza, Susan E.

doi:10.1016/s1054-139x(03)00057-0

Cited by 98 publications

(60 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many clinical conditions affecting bone show age-dependence. Several types of primary skeletal tumors, including osteosarcoma and Ewing's sarcoma, have a higher prevalence in children and adolescents than in adults (36,37). In addition, older patients (38-41) and older animals (42-44) recover more slowly after certain types of fracture.…”

Section: Discussionmentioning

confidence: 99%

Osteoblast expression of an engineered G _s -coupled receptor dramatically increases bone mass

Hsiao

Boudignon²,

Chang³

et al. 2008

Proc. Natl. Acad. Sci. U.S.A.

154

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Osteoblast expression of an engineered G _s -coupled receptor dramatically increases bone mass

Hsiao

Boudignon²,

Chang³

et al. 2008

Proc. Natl. Acad. Sci. U.S.A.

154

View full text Add to dashboard Cite

“…93 Age-related differences in histological subtypes have been observed. 98 Children with Hodgkin lymphoma are more likely to be positive for Epstein-Barr virus (EBV) than are adolescent and young adult patients. 99 Hodgkin lymphoma among adolescents and young adults may result from a delayed reaction to a common infectious exposure (not EBV) late in adolescence.…”

Section: Children and Adolescentsmentioning

confidence: 99%

Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations

Howe

Ries

et al. 2006

Cancer

374

280

View full text Add to dashboard Cite

BACKGROUNDThe American Cancer Society, Centers for Disease Control and Prevention, National Cancer Institute, and North American Association of Central Cancer Registries collaborate annually to provide U.S. cancer information, this year featuring the first comprehensive compilation of cancer information for U.S. Latinos.METHODSCancer incidence was obtained from 90% of the Hispanic/Latino and 82% of the U.S. populations. Cancer deaths were obtained for the entire U.S. population. Cancer screening, risk factor, incidence, and mortality data were compiled for Latino and non‐Latino adults and children (incidence only). Long‐term (1975–2003) and fixed‐interval (1995–2003) trends and comparative analyses by disease stage, urbanicity, and area poverty were evaluated.RESULTSThe long‐term trend in overall cancer death rates, declining since the early 1990s, continued through 2003 for all races and both sexes combined. However, female lung cancer incidence rates increased from 1975 to 2003, decelerating since 1991 and breast cancer incidence rates stabilized from 2001 to 2003. Latinos had lower incidence rates in 1999–2003 for most cancers, but higher rates for stomach, liver, cervix, and myeloma (females) than did non‐Latino white populations. Latino children have higher incidence of leukemia, retinoblastoma, osteosarcoma, and germ‐cell tumors than do non‐Latino white children. For several common cancers, Latinos were less likely than non‐Latinos to be diagnosed at localized stages.CONCLUSIONSThe lower cancer rates observed in Latino immigrants could be sustained by maintenance of healthy behaviors. Some infection‐related cancers in Latinos could be controlled by evidence‐based interventions. Affordable, culturally sensitive, linguistically appropriate, and timely access to cancer information, prevention, screening, and treatment are important in Latino outreach and community networks. Cancer 2006. Published 2006 by the American Cancer Society.

show abstract

“…This site distribution presents few differences compared to the US SEER registry data [8] as well as to the French epidemiology report [9], with over-representation of nasopharyngeal carcinomas (NPC) and gynecologic tumors compared to thyroid carcinomas. In SEER registry, thyroid carcinoma incidence rate is 15 fold higher than NPC and gonadal carcinomas [1], whereas in our series, 82 thyroid carcinomas, 40 NPC and 22 genital tract carcinomas were reported.…”

Section: Discussionmentioning

confidence: 71%

“…Eighty-two patients were treated for a papillary (69), follicular (8) and medullary (5) carcinoma. At initial diagnosis, lymph node metastases were present in 57 cases (52 papillary, 3 follicular and 2 medullary) with lung metastases in 6 patients.…”

Section: Thyroid Carcinomasmentioning

confidence: 99%

“…Only 2/7 patients with FL-HCC and 1/5 HCC were alive with a follow-up of 47, 77 and 74 months but after multiple recurrences treated with various combined therapies (multiple surgeries, chemotherapy, hyperthermic intraperitoneal chemotherapy, inhibitor tyrosine kinase, radiofrequency). The median survival of patients was 26 months (12-78) for FL-HCC and 16.5 months (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25) for HCC.…”

Section: Liver Carcinomamentioning

confidence: 99%

See 1 more Smart Citation

Overview of Carcinomas in Adolescents: A Descriptive Study Over Twenty Years

Fresneau¹,

Fabrè²,

Janot³

et al. 2015

Arch Surg Oncol

View full text Add to dashboard Cite

Cancer incidence in adolescents and young adults in the United States, 1992–1997

Cited by 98 publications

References 50 publications

Osteoblast expression of an engineered G _s -coupled receptor dramatically increases bone mass

Osteoblast expression of an engineered G _s -coupled receptor dramatically increases bone mass

Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations

Overview of Carcinomas in Adolescents: A Descriptive Study Over Twenty Years

Contact Info

Product

Resources

About

Cancer incidence in adolescents and young adults in the United States, 1992–1997

Cited by 98 publications

References 50 publications

Osteoblast expression of an engineered G s -coupled receptor dramatically increases bone mass

Osteoblast expression of an engineered G s -coupled receptor dramatically increases bone mass

Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations

Overview of Carcinomas in Adolescents: A Descriptive Study Over Twenty Years

Contact Info

Product

Resources

About

Osteoblast expression of an engineered G _s -coupled receptor dramatically increases bone mass

Osteoblast expression of an engineered G _s -coupled receptor dramatically increases bone mass